{"name":"NeuroBo Pharmaceuticals Inc.","slug":"neurobo-pharmaceuticals-inc","ticker":"","exchange":"","domain":"neurobo.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOZlBZVjRpWDlxdG5GRTY3VWRzM0xGZkRMdkhTSEU2TzZWSnF1UkM1bllaSzlkd0VNNjNMd0FxYmhrQnNGNlhibEVMY2lXMXRxYi1mNEtSUzV1azAtTzE3QWxPWndOTUJqdDdnZVl4VFdMdE1mZDZCS2xGYWdjdzlmdkxjNHUyeXl3dW5EZFRJYw?oc=5","date":"2024-11-19","type":"pipeline","source":"Fierce Pharma","summary":"NeuroBo Pharmaceuticals rebrands to become MetaVia - Fierce Pharma","headline":"NeuroBo Pharmaceuticals rebrands to become MetaVia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQUV82M212ZW1sLVh6Z0JEX3FlUVZseFhRbHVWWEFJTUhJbzJmY1ZHX0lnNGJBX3JZOTBYMDVBa1VPU0RPTkYzRmsxelpXSVlVblBGeWx1dFNQajNTMUR5WnU3VFR2RVVTU2Z1dFlxR1p1aWU0ZWt5Ujl3Y0pqQXVBZjZCdmxVR1g1RHVMSmhpNkNoQnhhbVBCM1Eyd3FIMUdWTmE4VFpLbERzYThUSnc?oc=5","date":"2024-07-30","type":"deal","source":"Contract Pharma","summary":"NeuroBo Signs Exclusive License Agreement with MTHERA for NB-01 - Contract Pharma","headline":"NeuroBo Signs Exclusive License Agreement with MTHERA for NB-01","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNSFBwcWVBQzRYMEFrRHRmN3RLRVkyZ2ZpbjdBbDVMb2I3RE56RUduYTRIZjg1WGYtTlpjMy1CT0tJSDI1MjdRc2wydk5ldXRvWlJaN21jeml6N2lNSjV2NmJLaU1PMU1neU14X21XVmdfZjlPMmt1VV9wNmZlcURmX3NoaDZSalFHa1JzUzVoY1pBbm1nMWJYcU9fal9ORGdXUTYxaTVRZw?oc=5","date":"2024-07-16","type":"pipeline","source":"BioWorld News","summary":"BIX 2024: From graveyard to breakthrough, MASH candidates on rise - BioWorld News","headline":"BIX 2024: From graveyard to breakthrough, MASH candidates on rise","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE1ZcHU2a0RjdHhWdlk5TjZXQTJaZEdaQm5henI5b2tpYkp3TU85NV9CUHIyLUN5Zml1RWsyRWJ5d0EzeXU3amxjZGJ3YU9GbjJsaTMtT1d3UV9hZG9Lejg1MkZMcFBqZnhkeXdsS1NsV0FvcFdHT1JaWg?oc=5","date":"2024-07-02","type":"pipeline","source":"The Pharma Letter","summary":"NeuroBo Pharmaceuticals | One to watch | The Pharmaletter - The Pharma Letter","headline":"NeuroBo Pharmaceuticals | One to watch | The Pharmaletter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgJBVV95cUxNSHcteVN0OTIybFdBc21NV1ZYYWZ0RzktMVl2Mm9nbGNDclJHV1JwZ0lTWEJNYnZKNmtoOW5sQThvakpmTVFzRnVldTgtNFN4R0tlZmtUaUliWTVXaWJWUkFJOUhfXzluZ0k4RENfbXBITWFuLUN3dHdLVWJYRHJSYW5RanprZnphcFFnOGxrNGdPaDhUU29fWktBd1g5YnZnRTN3V0VUQ1pKcy1CcGR5Wm1Sc1VweEs3SHhiNHNZemlhemJ5UDd1a0xVaEJxRDNRTFkyMFNmT0VqM3cyWnc2RERjcXVZbEd4NlE1akYxSjZGU2xtV2FXQmlzR3BJRTRuX2RXcHBaWmNadzhpY2VCeS1RUnIyRzBsTElEUWVUVE1nOWFpWG16MFdIVVJrTnd6RDNvMUloNFRjQXBDRS1zT1VaNHo5LUtkY2NpV3V3?oc=5","date":"2024-06-22","type":"pipeline","source":"PR Newswire","summary":"NeuroBo Pharmaceuticals' DA-1726 Demonstrated Superiority in Weight Loss, Retention of Lean Body Mass, and Lipid-Lowering Effects Compared to Survodutide, in Pre-Clinical Models - PR Newswire","headline":"NeuroBo Pharmaceuticals' DA-1726 Demonstrated Superiority in Weight Loss, Retention of Lean Body Mass, and Lipid-Lowerin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFAyMl8zNkRsekdhcW9tM3g0Wk9XSjRxVlIyVThaMHlrTHVvQVpfZEJsSGNNRXB1UXFJTEVOS3oyXzZDeHFocUtDc3FNd09abzdQWTh0V3J5RVhiQjVpUEJVMHB2QnB2UXlmSC1RbHRn?oc=5","date":"2022-12-23","type":"pipeline","source":"KED Global","summary":"Dong-A ST incorporates NeuroBo as subsidiary - KED Global","headline":"Dong-A ST incorporates NeuroBo as subsidiary","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiSEFVX3lxTFBoOExPcnp1V1lidWtQeTMtckN3V1dyQjZkWkxtZXEzQ1FMYWlVYngxTG90VkpVU1p1RzZVTDhBRUZTaFRTdFEyZg?oc=5","date":"2021-03-24","type":"pipeline","source":"CoinCodex","summary":"NeuroBo Pharmaceuticals (NRBO) Stock Live Price, Chart & News - CoinCodex","headline":"NeuroBo Pharmaceuticals (NRBO) Stock Live Price, Chart & News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTE9ndy1heUFGNUMxdEtneWJBRE56bmVZYV83ZmI4cHVJcnFuck95V0RFcjM0RzVMUzdSRGNTQkl6dUpMYm92S3JPWVRIY3F2ajZKZXJpR0ttTko?oc=5","date":"2019-07-25","type":"pipeline","source":"theinvestor.co.kr","summary":"S. Korean VC-backed NeuroBo merges with Nasdaq-listed Gemphire - theinvestor.co.kr","headline":"S. Korean VC-backed NeuroBo merges with Nasdaq-listed Gemphire","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTFBCeUVnQlg5MXdaa3J4TzR2NVJPUHFvclBIdGdVOHhYdng0SFNKcDZVVUx6MVhQVEJINjBvRnVCOEFLQ0xmV2xwN0Y1Wjg5ZHlVVXhnLWdPV19sLTR5a1R4cWZ5a0lWamdEQklaa9IBcEFVX3lxTE1nWmRfS3RTVmt0eWpOVkFydmZXYjNyRGgxYUo1eUVMXzI5ZTNfUFVJN1UxNDFUM1RRU3dFSjljQkY3N0dpUzNTVGM4ZFgwakJKVGtSOEJHSElkc3hDNG00SVBvcVc4WFViUDNZYmRUcDQ?oc=5","date":"2018-01-19","type":"deal","source":"koreabiomed.com","summary":"Dong-A ST stock surges upon export deal announcement - koreabiomed.com","headline":"Dong-A ST stock surges upon export deal announcement","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}